Mazdutide shows impressive weight loss and waist reduction in a major phase 3 trial for Chinese adults with obesity. Significant cardiometabolic benefits, but GI side effects need attention. 💊📉
www.news-medical.net/news/2026060... #Mazdutide #Obesity @jama.com
Once-weekly 9 mg mazdutide produced clinically meaningful weight loss in Chinese adults with obesity, reducing body weight by 16.65% after 60 weeks versus 1.50% with placebo. The phase 3 GLORY-2 trial...
